The link between bone disease and cardiovascular complications in hemodialysis patients
Keywords:
cardiovascular complication, hemodialysis, echocardiographyAbstract
Introduction: The burden on the cardiovascular system is the main cause of mortality in chronic renal patients, and bone disease, which also may cause disability, is one of the most important complications in those patients. The aim of this study was to determine the link between cardiovascular and bone disease, which frequently occur together.
Methods: In this matched case-control study, 70 subjects were subjected for full laboratory assessment as well as estimation of parathyroid hormone (PTH) level, vitamin D level, complete echocardiography, and dual energy absorptiometry. Of the 70 patients, 50 were on regular hemodialysis, and there were 20 normal controls matched with the patients with respect to age and gender.
Results: There was a significant decrease in the mean value of serum vitamin D in the hemodialysis patients, i.e., their mean value was 20.47 ± 9.60 whereas the controls had a mean value of 37.15 ± 7.67. Thus, there was a highly-significant, negative correlation between vitamin D and left ventricular mass (LVM) in the patients. We found that there was a highly-significant increase in the mean PTH levels of the patients (820.22 ± 393.51), whereas it was 57.60 ± 13.72 for the controls. The statistical significance was less than 0.001, a highly-significant increase in the mean of the T score levels in the patients (-2.15 ± 2.56), whereas it was -0.47 ± 0.71 for the controls with a statistical significance of less than 0.001. There also was a highly-significant correlation between the T score and LVM.
Conclusion: A significant correlation was found between bone disease and the occurrence of a left ventricular mass. We recommend early strict correction of the serum levels of vitamin D, PTH, calcium, and phosphorus.
References
Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality,
and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8): 2208-18. doi:
1097/01.ASN.0000133041.27682.A2. PMID: 15284307.
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis
patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47(3): 884-90. doi:
1038/ki.1995.132. PMID: 7752588.
US Renal Data System: USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United
States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney
Diseases, 2012.
US Renal Data System: USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United
States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney
Diseases, 2009.
Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and
classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global
Outcomes (KDIGO). Kidney Int. 2006; 69(11): 1945-53. doi: 10.1038/sj.ki.5000414. PMID: 16641930.
Mejia N, Roman-Garcia P, Miar AB, Tavira B, Cannata-Andia JB. Chronic kidney disease–mineral and
bone disorder: a complex scenario. Nefrologia. 2011; 31(5): 514-19. doi: 10.3265/Nefrologia.pre2011.
PMID: 21959717.
Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease
progression, and therapeutic options. Clin J Am Soc Nephrol. 2011; 6(4): 913-21. doi:
2215/CJN.06040710. PMID: 21454719.
Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, et al. Diagnosis, assessment, and
treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004; 43(3): 558-65.
doi: 10.1053/j.ajkd.2003.12.003. PMID: 14981615.
Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, et al. Vitamin D status and clinical
outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2011;
(3): 1024-32. doi: 10.1093/ndt/gfq606. PMID: 20947538.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-81. doi: 10.1056/NEJMra070553.
PMID: 17634462.
Fallo F, Catena C, Camozzi V, Luisetto G, Cosma C, Plebani M, et al. Low serum 25-hydroxyvitamin D
levels are associated with left ventricular hypertrophy in essential hypertension. Nutr Metab Cardiovasc
Dis. 2012; 22(10): 871-6. doi: 10.1016/j.numecd.2011.06.001. PMID: 21937207.
Mozos I, Marginean O. Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int.
; 2015: 109275. doi: 10.1155/2015/109275. PMID: 26000280, PMCID: PMC4427096.
Lai S, Coppola B, Dimko M, Galani A, Innico G, Frassetti N, et al. Vitamin D deficiency, insulin
resistance, and ventricular hypertrophy in the early stages of chronic kidney disease. Ren Fail. 2014; 36(1):
-64. doi: 10.3109/0886022X.2013.832308. PMID: 24028070.
Assalin HB, Rafacho BP, dos Santos PP, Ardisson LP, Roscani MG, Chiuso-Minicucci F, et al. Impact of
the length of vitamin D deficiency on cardiac remodeling. Circ Heart Fail. 2013; 6(4): 809-16. doi:
1161/CIRCHEARTFAILURE.112.000298. PMID: 23709660.
Patange AR, Valentini RP, Gothe MP, Du W, Pettersen MD. Vitamin D deficiency is associated with
increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Pediatr
Cardiol. 2013; 34(3): 536-42. doi: 10.1007/s00246-012-0489-z. PMID: 22941497.
Cozzolino M, Ketteler M, Zehnder D. The vitamin D system: A crosstalk between the heart and kidney.
Eur J Heart Fail. 2010; 12(10): 1031-41. doi: 10.1093/eurjhf/hfq112. PMID: 20605845.
Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS, et al. Vitamin D status and risk of
cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011; 19(4):
-201. doi: 10.1097/CRD.0b013e31821da9a5. PMID: 21646873.
Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M. Vitamin D as a Novel Nontraditional Risk
Factor for Mortality in Hemodialysis Patients. Ther Apher Dial. 2009; 13(4): 268-72. doi: 10.1111/j.1744- 9987.2009.00722.x. PMID: 19695057.
Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality
among incident hemodialysis patients. Kidney Int. 2007; 72(8): 1004-13. doi: 10.1038/sj.ki.5002451.
PMID: 17687259.
Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin
Invest. 2005; 35(5): 290-304. doi: 10.1111/j.1365-2362.2005.01487.x. PMID: 15860041.
Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, et al. Vitamin D Affects Survival
Independently of Vascular Calcification in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009; 4(6):
-35. doi: 10.2215/CJN.00260109. PMID: 19443628, PMCID: PMC2689889.
Chang J, Ye XG, Hou YP, Wu JL, Li SL, Sun QM. Vitamin D Level is Associated with Increased Left
Ventricular Mass and Arterial Stiffness in Older Patients with Impaired Renal Function. Med Sci Monit.
; 21: 3993-9. PMID: 26691016, PMCID: PMC4692575.
Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol.
; 4(9): 1515-22. doi: 10.2215/CJN.02260409. PMID: 19696220.
Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al. Cholecalciferol supplementation in
hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Clin J Am Soc Nephrol. 2010; 5(5): 905-11. doi: 10.2215/CJN.06510909. PMID: 20203163, PMCID:
PMC2863968.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine
regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2): 229-38. doi: 10.1172/JCI0215219.
PMID: 12122115, PMCID: PMC151055.
Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU. 1,25(OH)2-vitamin D3 actions on cell
proliferation, size, gene expression, and receptor localization in the HL-1 cardiac myocyte. J Steroid
Biochem Mol Biol. 2007; 103(3-5): 533-7. doi: 10.1016/j.jsbmb.2006.12.099. PMID: 17276054, PMCID:
PMC1890037.
Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2-vitamin D3 and retinoic acid antagonize endothelin- stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996; 97(7): 1577-88. doi:
1172/JCI118582. PMID: 8601621, PMCID: PMC507220.
London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular
hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am
Soc Nephrol. 2001; 12(12): 2759-67. PMID: 11729246.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation,
classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1): 1-266. PMID: 11904577.
Leibowitz D. Left Ventricular Hypertrophy and Chronic Renal Insufficiency in the Elderly. Cardiorenal
Med. 2014; 4(3-4): 168-175. doi: 10.1159/000366455. PMID: 25737681, PMCID: PMC4299265.
Riggs BL, Melton LJ 3rd. The world wide problem of osteoporosis: insights offered by epidemiology.
Bone. 1995; 17(5): 505-11. doi: 10.1016/8756-3282(95)00258-4. PMID: 8573428.
Limori S, Mori y, Akita w, Kuyama T, Takada S, Asai T, et al. Diagnostic usefulness of bone mineral
density and biochemical markers of bone turnover in predicting fracture in CKD stage 5patients. a single
cohort study. Nephrol Dial Transplant. 2012; 27(1): 345-51. doi: 10.1093/ndt/gfr317. PMID: 21652550.
Alissa EM, Alnahdi W, Alama N, Ferns GA. Bone mineral density and cardiovascular risk factors in post
menopausal women with coronary artery disease. Bone key rep. 2015; 4: 758. doi:
1038/bonekey.2015.127. PMID: 26587227, PMCID: PMC4644069.
Avramovski P, Avramovska M, Sikole A. Bone Strength and Arterial Stiffness Impact on Cardiovascular
Mortality in a General Population. J Osteoporosa. 2016; 2016: 7030272. doi: 10.1155/2016/7030272.
PMID: 27047700, PMCID: PMC4800107.
den Uyl D, Nurmohamed MT, van Tuyl LH, Raterman HG, Lems WF. (Sub)clinical cardiovascular disease
is associated with increased bone loss and fracture risk; a systematic review of the association between
cardiovascular disease and osteoporosis. Arthritis Res Ther. 2011; 13(1): 5. doi: 10.1186/ar3224. PMID:
, PMCID: PMC3241350.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
